VYNE vs ACTU

Comparison between VYNE Therapeutics Inc (VYNE, Company) and Actuate Therapeutics Inc (ACTU, Company).

Both VYNE and ACTU are from the Healthcare sector.

VYNE vs ACTU - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	VYNE(COMPANY)	ACTU(COMPANY)
Market Cap	$30M	$30M
Max Drawdown	N/A	90.34%
Sharpe Ratio	0.28	-1.38
5Y Beta	1.14	1.01
Industry	Biotechnology	Biotechnology
P/E Ratio	-0.51	-1.32
5Y EPS CAGR	-49.07%	N/A
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	N/A	-65.36%
P/S Ratio	66.01	N/A
P/B Ratio	1.20	8.54

Market Cap

VYNE

$30M

Winner

ACTU

$30M

Max Drawdown

VYNE

N/A

ACTU

90.34%

Sharpe Ratio

Winner

VYNE

0.28

ACTU

-1.38

5Y Beta

VYNE

1.14

Winner

ACTU

1.01

Industry

VYNE

Biotechnology

ACTU

Biotechnology

P/E Ratio

VYNE

-0.51

Winner

ACTU

-1.32

5Y EPS CAGR

VYNE

-49.07%

ACTU

N/A

Debt to Equity

VYNE

0.00%

ACTU

0.00%

Free Cash Flow Yield

VYNE

N/A

ACTU

-65.36%

P/S Ratio

VYNE

66.01

ACTU

N/A

P/B Ratio

Winner

VYNE

1.20

ACTU

8.54

VYNE vs ACTU - Historical Returns

Returns include dividend reinvestment.

Period	VYNE	ACTU
1 month	N/A	-31.55%
3 months	N/A	-59.65%
6 months	N/A	-78.90%
1 year	N/A	-83.24%
Max(CAGR)	N/A	-64.35%

VYNE

N/A

ACTU

-31.55%

VYNE

N/A

ACTU

-59.65%

VYNE

N/A

ACTU

-78.90%

VYNE

N/A

ACTU

-83.24%

Max(CAGR)

VYNE

N/A

ACTU

-64.35%

VYNE vs ACTU - Annual Returns (2024 - 2026)

Returns include dividend reinvestment.

Year	VYNE	ACTU
2026	+0.00%	-80.93%
2025	N/A	-23.12%
2024	N/A	-7.55%

VYNE vs ACTU Drawdown Comparison

The maximum drawdown for ACTU was -90.34%, occurring on Jul 27, 2026. This drawdown has not yet recovered.

The current ACTU drawdown is -90.34%.

Rank	VYNE	ACTU
#1	N/A	-90.34% May 30, 2025 - Jul 27, 2026
#2	N/A	-40.82% Jan 23, 2025 - May 30, 2025
#3	N/A	-36.61% Aug 14, 2024 - Oct 28, 2024
#4	N/A	-26.65% Oct 28, 2024 - Jan 21, 2025